41 related articles for article (PubMed ID: 32389938)
1. Design, synthesis and biological evaluation of bifunctional inhibitors of membrane type 1 matrix metalloproteinase (MT1-MMP).
Cuffaro D; Nuti E; Gifford V; Ito N; Camodeca C; Tuccinardi T; Nencetti S; Orlandini E; Itoh Y; Rossello A
Bioorg Med Chem; 2019 Jan; 27(1):196-207. PubMed ID: 30522899
[TBL] [Abstract][Full Text] [Related]
2. Discovery of 1-(5-bromopyrazin-2-yl)-1-[3-(trifluoromethyl)benzyl]urea as a promising anticancer drug via synthesis, characterization, biological screening, and computational studies.
Mohammed YHI; Shamkh IM; Alharthi NS; Shanawaz MA; Alzahrani HA; Jabbar B; Beigh S; Alghamdi S; Alsakhen N; Khidir EB; Alhuthali HM; Karamalla THE; Rabie AM
Sci Rep; 2023 Dec; 13(1):22824. PubMed ID: 38129413
[TBL] [Abstract][Full Text] [Related]
3. Derivatives of D(-) glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-I: Synthesis, biological screening and in silico binding interaction analysis.
Das S; Mondal S; Patel T; Himaja A; Adhikari N; Banerjee S; Baidya SK; De AK; Gayen S; Ghosh B; Jha T
Eur J Med Chem; 2024 Aug; 274():116563. PubMed ID: 38843586
[TBL] [Abstract][Full Text] [Related]
4. Molecular insights in repurposing selective COX-2 inhibitor celecoxib against matrix metalloproteinases in potentiating delayed wound healing: a molecular docking and MMPB/SA based analysis of molecular dynamic simulations.
Mude L; Jupudi S; Swaroop AK; Tallapaneni V; Karri VVSR
J Biomol Struct Dyn; 2024 Mar; 42(5):2437-2448. PubMed ID: 37160705
[TBL] [Abstract][Full Text] [Related]
5. New Derivatives of
Balakina A; Gadomsky S; Kokovina T; Sashenkova T; Mishchenko D; Terentiev A
Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003553
[TBL] [Abstract][Full Text] [Related]
6. 3,3'-((3,4,5-trifluoropHenyl)methylene)bis(4-hydroxy-2H-chromen-2-one) inhibit lung cancer cell proliferation and migration.
Luo W; Chang G; Lin D; Xie H; Sun H; Li Z; Mo S; Wang R; Wang Y; Zheng Z
PLoS One; 2024; 19(5):e0303186. PubMed ID: 38776295
[TBL] [Abstract][Full Text] [Related]
7. Selective Allosteric Inhibition of MMP9 Is Efficacious in Preclinical Models of Ulcerative Colitis and Colorectal Cancer.
Marshall DC; Lyman SK; McCauley S; Kovalenko M; Spangler R; Liu C; Lee M; O'Sullivan C; Barry-Hamilton V; Ghermazien H; Mikels-Vigdal A; Garcia CA; Jorgensen B; Velayo AC; Wang R; Adamkewicz JI; Smith V
PLoS One; 2015; 10(5):e0127063. PubMed ID: 25961845
[TBL] [Abstract][Full Text] [Related]
8. Assessing structural insights into in-house arylsulfonyl L-(+) glutamine MMP-2 inhibitors as promising anticancer agents through structure-based computational modelling approaches.
Baidya SK; Banerjee S; Ghosh B; Jha T; Adhikari N
SAR QSAR Environ Res; 2023; 34(10):805-830. PubMed ID: 37850742
[TBL] [Abstract][Full Text] [Related]
9. Laminaran from brown alga Dictyota dichotoma and its sulfated derivative as radioprotectors and radiosensitizers in melanoma therapy.
Malyarenko OS; Usoltseva RV; Zvyagintseva TN; Ermakova SP
Carbohydr Polym; 2019 Feb; 206():539-547. PubMed ID: 30553355
[TBL] [Abstract][Full Text] [Related]
10. A fragment-based exploration of diverse MMP-9 inhibitors through classification-dependent structural assessment.
Baidya SK; Banerjee S; Ghosh B; Jha T; Adhikari N
J Mol Graph Model; 2024 Jan; 126():108671. PubMed ID: 37976979
[TBL] [Abstract][Full Text] [Related]
11. Exploring natural anthraquinones as potential MMP2 inhibitors: A computational study.
Jamshidi S; Rostami A; Shojaei S; Taherkhani A; Taherkhani H
Biosystems; 2024 Jan; 235():105103. PubMed ID: 38123060
[TBL] [Abstract][Full Text] [Related]
12. Structure-Based Optimization and Biological Evaluation of Potent and Selective MMP-7 Inhibitors for Kidney Fibrosis.
Abe-Sato K; Tabuse H; Kanazawa H; Kamitani M; Endo M; Tokura S; Wakabayashi S; Yahara T; Takeda T; Hitaka K; Gunji E; Kojima N; Oka Y
J Med Chem; 2023 Nov; 66(21):14653-14668. PubMed ID: 37861435
[TBL] [Abstract][Full Text] [Related]
13. Recent progress in the strategic incorporation of fluorine into medicinally active compounds.
Haranahalli K; Honda T; Ojima I
J Fluor Chem; 2019 Jan; 217():29-40. PubMed ID: 31537946
[TBL] [Abstract][Full Text] [Related]
14. Ligand-based pharmacophore modeling and molecular dynamic simulation approaches to identify putative MMP-9 inhibitors.
Sanapalli BKR; Yele V; Jupudi S; Karri VVSR
RSC Adv; 2021 Aug; 11(43):26820-26831. PubMed ID: 35480006
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of 4-phenoxybenzenesulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Mao J; Zhang H; Wang X; Gao J; Tang J; Zhang J
Biosci Trends; 2020 Jul; 14(3):192-199. PubMed ID: 32389938
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel benzofuroxan-based pyrrolidine hydroxamates as matrix metalloproteinase inhibitors with nitric oxide releasing activity.
Zhang H; Wang X; Mao J; Huang Y; Xu W; Duan Y; Zhang J
Bioorg Med Chem; 2018 Aug; 26(15):4363-4374. PubMed ID: 30093347
[TBL] [Abstract][Full Text] [Related]
17. Halting Tumor Progression via Novel Non-Hydroxamate Triazole-Based Mannich Bases MMP-2/9 Inhibitors; Design, Microwave-Assisted Synthesis, and Biological Evaluation.
Albelwi FF; Teleb M; Abu-Serie MM; Moaty MNAA; Alsubaie MS; Zakaria MA; El Kilany Y; Aouad MR; Hagar M; Rezki N
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638665
[TBL] [Abstract][Full Text] [Related]
18. Sulfonyl phosphonic 1,4-dithia-7-azaspiro[4,4]nonane derivatives as matrix metalloproteinase inhibitors: Synthesis, a docking study, and biological evaluation.
Zhang H; Li X; Wang X; Xu W; Zhang J
Drug Discov Ther; 2017; 11(3):118-125. PubMed ID: 28757512
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview.
Mondal S; Adhikari N; Banerjee S; Amin SA; Jha T
Eur J Med Chem; 2020 May; 194():112260. PubMed ID: 32224379
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
